Although the risk for treatment failure for PP compared with oral APs did not reach statistical significance for the recent‐onset subpopulation, this is likely driven by the low power of this post hoc comparison and the sample size ( n = 77).
← all excerpts
Treatment effect with paliperidone palmitate compared with oral antipsychotics in patients with recent-onset versus more chronic schizophrenia and a history of criminal justice system involvement.
1
—
—